Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Sci Rep ; 13(1): 16340, 2023 09 28.
Artículo en Inglés | MEDLINE | ID: mdl-37770630

RESUMEN

Peritoneal calcification is a prominent feature of the later stage of encapsulating peritoneal sclerosis (EPS) in patients undergoing long-term peritoneal dialysis (PD). However, the pathogenesis and preventive strategy for peritoneal calcification remain unclear. Peritoneum samples from EPS patients were examined histologically. Peritoneal calcification was induced in mice by feeding with an adenine-containing diet combined with intraperitoneal administration of lipopolysaccharide and a calcifying solution containing high calcium and phosphate. Excised mouse peritoneum, human mesothelial cells (MeT5A), and mouse embryonic fibroblasts (MEFs) were cultured in calcifying medium. Immunohistochemistry confirmed the appearance of osteoblastic differentiation-marker-positive cells in the visceral peritoneum from EPS patients. Intraperitoneal administration of magnesium suppressed peritoneal fibrosis and calcification in mice. Calcifying medium increased the calcification of cultured mouse peritoneum, which was prevented by magnesium. Calcification of the extracellular matrix was accelerated in Met5A cells and MEFs treated with calcification medium. Calcifying medium also upregulated osteoblastic differentiation markers in MeT5A cells and induced apoptosis in MEFs. Conversely, magnesium supplementation mitigated extracellular matrix calcification and phenotypic transdifferentiation and apoptosis caused by calcifying conditions in cultured MeT5A cells and MEFs. Phosphate loading contributes to the progression of EPS through peritoneal calcification and fibrosis, which can be prevented by magnesium supplementation.


Asunto(s)
Calcinosis , Diálisis Peritoneal , Fibrosis Peritoneal , Humanos , Animales , Ratones , Peritoneo/patología , Fibrosis Peritoneal/etiología , Fibrosis Peritoneal/prevención & control , Fibrosis Peritoneal/patología , Magnesio/farmacología , Fibroblastos/patología , Diálisis Peritoneal/efectos adversos , Calcinosis/patología
2.
Intern Med ; 55(14): 1899-905, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27432100

RESUMEN

We present the case of a non-dialyzed patient with chronic kidney disease and biopsy-proven calciphylaxis who presented with painful cutaneous ulcers on both legs. The skin ulcers drastically improved within 6 months after the initiation of hemodialysis, aggressive wound care, the control of a mineral and bone disorder, and the administration of sodium thiosulfate and hyperbaric oxygen therapy. Notably, the patient's serum levels of C-reactive protein and calciprotein particles decreased and her serum albumin and fetuin-A levels increased in parallel with the alleviation of her calciphylaxis. This case highlights the importance of applying combined medical treatment to calciphylaxis and suggests the possible involvement of calciprotein particles in the pathogenesis of calciphylaxis.


Asunto(s)
Calcifilaxia/complicaciones , Calcifilaxia/terapia , Oxigenoterapia Hiperbárica/métodos , Insuficiencia Renal Crónica/complicaciones , Tiosulfatos/uso terapéutico , Proteína C-Reactiva , Femenino , Humanos , Persona de Mediana Edad , Diálisis Renal/métodos , Albúmina Sérica/análisis , Úlcera Cutánea/terapia , alfa-2-Glicoproteína-HS/análisis
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA